The Neglected Dimension of Global Security A Framework to Counter Infectious Disease Crises (2016) / Chapter Skim
Currently Skimming:
1 Introduction
1 Introduction
Pages 9-16
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 9... ...
• The Harvard Global Health Institute and the Lon Past outbreaks of other diseases, including H1N1 don School of Hygiene & Tropical Medicine set up influenza, severe acute respiratory syndrome (SARS) , the Independent Panel on the Global Response to and human immunodeficiency virus (HIV)
|
From page 10... ...
and private stakeholders Managing the Risk World Economic Forum and Explored public–private Report published June 2015 and Impact of Future Boston Consulting Group partnerships when Epidemics: Options responding to epidemics for Public–Private using lessons learned from Collaboration the Ebola response. Independent Panel to World Health Organization Convened by the WHO Report published July 2015 Assess WHO's Response to (WHO)
|
From page 11... ...
Interrelations among sectors will be studied. Conclu sions and actionable recommendations will be offered to guide policy makers, international funders, civil society organizations, and the private sector, with the understanding that stakeholders may adapt and apply the recom mended architecture to global health emergencies beyond epidemic infectious diseases.
|
From page 12... ...
holders with relevant expertise and global representation, The statement of task required that the Commis- was formed to ensure the independence and objectivity sion deliberate and evaluate options in these four topic of the Commission, and to protect integrity and maindomains to strengthen global, regional, national, and lo- tain public confidence in the process. The IOG steered cal systems to better prepare, detect, and respond to epi- the Commission throughout the process, including by demic infectious diseases.
|
From page 13... ...
• August 19–21: A Workshop on Research and De4. Provide guidelines for the report review process: velopment of Medical Products, Hong Kong, China As a final check on the quality and objectivity of • August 27–28: A Workshop on Pandemic Financ the study, the IOG determined the characteristics of ing, Washington, DC, United States of America the external review process for the final report and • September 1–2: Governance for Global Health -- A provided suggestions for specific processes.
|
From page 14... ...
uted to other initiatives, this study preserved its high de- • Chapter 5 presents the importance of acceleratgree of independence and the integrity of its processes as ing medical products research and development to outlined in this chapter. counter the threat of infectious diseases and outlines a global strategy to facilitate this -- including a plan REVIEW PROCESS to develop a Pandemic Product Development ComThis report has been reviewed in draft form by indi- mittee, invest in a comprehensive portfolio of medividuals chosen for their diverse perspectives and tech- cal products, conduct research according to high nical expertise.
|
From page 15... ...
http://www.who.int/csr/disease/ebola/one-year-report/ London School of Hygiene & Tropical Medicine convene independent factors/en (accessed September 1, 2010)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.